Your local 340B hospitals and federally qualified health centers aren’t the villains in this story. They are the safety net.

If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

Bausch Health has exited Medicaid and a federal government drug discount scheme known as 340B, a step that suggests more ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...

Inaccurate information, pushbacks and undue limitations imposed by pharmaceutical manufacturers pose a threat to the 340B ...

The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and Inappropriate Service Reduction model.

President Donald Trump recently shared a story about a friend who bought a weight loss drug in the UK for $88 —compared to a staggering $1,300 in New York. It’s an eye-popping contrast, the kind that ...

Momentum is mounting in the Senate to reform a prescription drug pricing program whose rapid growth, lawmakers contend, has ...

To discourage price hikes on brand-name drugs, the IRA requires manufacturers to pay inflation rebates to Medicare if prices ...